Melodi Health raised $10.75M in a Series A funding led by undisclosed investors to further its pivotal breast reconstruction trial.

Sep 02, 2024•over 1 year ago

Amount Raised

$10.8 Million

Round Type

series a

MinneapolisHealth Care

Description

Melodi Health has successfully secured $10.75 million in Series A funding. This investment will support the enrollment of the first patient in its pivotal breast reconstruction trial.

Company Information

Company

Melodi Health

Location

1414 MARSHALL ST. NE

Minneapolis, Minnesota, United States

About

Melodi Health offers novel technologies that improve patient outcomes for women undergoing breast surgery. Melodi Health manufactures the Melodi Matrix, designed to support the soft tissue space around a prosthetic device while delivering antibiotics to the surrounding tissue. The Melodi Matrix is currently an investigational device being studied in a prospective, multi-center, randomized, controlled clinical trial in breast reconstruction.

Related People

3 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Melodi Health raised $10.75M in a Series A funding led by undisclosed investors to further its pivotal breast reconstruction trial.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information